Sign in
4

Changes in Ownership

Emergent BioSolutions Inc. Filed Acc 0001367644-23-000014

EVP, Chief Financial Officer gave up 2,396 shares (to pay taxes)

  • EVP, Chief Financial Officer acquired 101 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

LINDAHL RICHARD S · EVP, Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-02-08 Grant or award : show line 1 in the form +101 21,797 D
2023-02-08 Shares withheld for taxes : show line 2 in the form −2,396 $13.25 $31,747 19,401 D
Loading xslF345X03/wf-form4_167607927638617.xml…